Replies to post #180675 on Biotech Values

[DewDiligence]

FDA panel backs GSK’s Mepolizumab for asthma in adults only:

http://in.reuters.com/article/2015/06/11/us-glaxosmithkline-asthma-fda-idINKBN0OR2N720150611

The dosing is q4w by injection.